Story perspectives

Philips Acquires SpectraWAVE to Enhance Coronary Imaging

12/15/2025

28 4

Summary

Story summary

Philips has acquired SpectraWAVE to boost its real-time coronary imaging platform, with undisclosed financial terms.
Roy Jakobs, Philips Chief Executive Officer, emphasized the commitment to AI-powered patient care.
SpectraWAVE's X1-FFR has FDA clearance and offers pressure-wire-free angiogram capabilities.
The HyperVue system combines optical coherence tomography and near-infrared spectroscopy.
Philips plans to integrate these technologies with the Azurion platform serving over 7.6 million patients annually in 80 countries.

1 of 1

Story summary

Philips has acquired SpectraWAVE to boost its real-time coronary imaging platform, with undisclosed financial terms.
Roy Jakobs, Philips Chief Executive Officer, emphasized the commitment to AI-powered patient care.
SpectraWAVE's X1-FFR has FDA clearance and offers pressure-wire-free angiogram capabilities.
The HyperVue system combines optical coherence tomography and near-infrared spectroscopy.
Philips plans to integrate these technologies with the Azurion platform serving over 7.6 million patients annually in 80 countries.